III International Conference on Psychedelics

FUERTEDÉLICA

BUY YOUR TICKET

00Days
00Hours
00Minutes
00Seconds

Welcome to the third edition of Fuertedélica, an international conference on psychedelics and mental health

In 2024, MDMA was expected to obtain authorization for medical use, marking a historic milestone in psychedelic therapies. However, the FDA’s recent decision not to approve its therapeutic use has frustrated these expectations, highlighting the complex dynamics of economic and political interests that continue to hinder the medical recognition of certain psychedelic substances. This setback underscores the need for continued research and debate around the benefits and risks associated with these therapies, particularly at a time when the integration of substances such as psilocybin, LSD and ayahuasca into modern medicine seems closer than ever. This is in addition to the availability of ketamine, which is already used in numerous clinics in Spain within the framework of psychedelic-assisted psychotherapy.

Fuertedélica provides a comprehensive conference that addresses the different spectrums of psychedelic cultures, ranging from medical systems that incorporate psychoactive plants to drug policies, contemporary psychedelic culture and therapeutic applications of these compounds. The event will be organized around five round tables, with various specialists sharing their perspectives on these substances and their impact on the field of mental health.

This event is set to be an essential platform for dialogue, learning and deepening the understanding of the interconnections between psychedelics and various sectors of our life and society.

Fuertedélica offers its attendees a unique opportunity to interact with others interested in the world of psychedelia, as well as internationally renowned professionals, in a relaxed and friendly environment. Set in the idyllic surroundings of Fuerteventura island, the weekend includes not only conferences but also informal spaces that serve as meeting points for exchanging ideas, forming alliances, collaborations, or simply enjoying moments of camaraderie. Book your early bird tickets now before they sell out. Don’t miss it!

We invite researchers to present their scientific posters! Send us an e-mail detailing the title of your paper and your abstract.

Latest research

Generating alliances

Networking

DISCUSSION

Speakers

0 +

Seats

Days

speakers

Giorgio Samorini

(Ethnobotanist, Italy)

Giorgio Samorini was born in Bologna, Italy, in 1957. He is an independent ethnobotanical researcher who has been investigating the traditional use of psychoactive plants and mushrooms in various cultures for decades. He has conducted research among ethnic groups in Africa, Latin America, and Asia. Among his notable discoveries is the identification of the oldest known cult of psychoactive mushrooms in the Sahara Desert, dating back 9,000 years, and the study of the modern Bwiti cult.

Fernando Caudevilla - Doctor X

(Family doctor specialized in psychoactive substances, Spain)

Currently, he balances his role as a family physician at a health center with various projects and activities related to harm reduction, therapeutic use of psychedelics, chemsex, and cryptomarkets of the Deep Web, among others.

Òscar Parés

(Anthropologist, ICEERS, Spain)

Òscar Parés has a degree in Philosophy, Anthropology and a master's degree in Drug Addiction. He is the Deputy Director of ICEERS and coordinates the Synaptica Clinic. He has promoted the community development process that has resulted in the creation of the federation Red Micelio.

Javier Hidalgo

(Psychedelic researcher, Spain)

Trained in Biomedicine at the Autonomous University of Barcelona, he holds a master's degree in Neuroscience from the Rovira i Virgili University. Interested in the intersection of science and philosophy, he has conducted studies on public health in cannabis users and a review on DMT at ICEERS. He has presented his work at international conferences such as Breaking Convention 2023 and ICPR 2024.

Estefanía Moreno

(Medical doctor and psychotherapist, Spain)

She holds a degree in Medicine, a master's in Transpersonal Psychology, Psychoneuroimmunology, and Integrative Medicine. Currently, she works as a physician and psychotherapist at the Synaptica Clinic, providing comprehensive support in ketamine-assisted psychotherapy processes.

Maja Kohek

(Medical anthropologist, ICEERS, Slovenia)

Maja holds a PhD in Medical Anthropology and Global Health and is a member of the Medical Anthropology Research Center (MARC) at Rovira i Virgili University in Tarragona, Spain. She works currently as a Research Coordinator at ICEERS, where her work focuses on the ritual use of psychoactive plants such as cannabis and ayahuasca, especially in the context of Global Mental Health and drug policy.

Dóra Révész

(Epidemiologist / Psychedelic integration coach, The Netherlands)

Dóra Révész (PhD) is an independent postdoctoral researcher/epidemiologist, and the founder of the Psychedelic Association Fuerteventura. In collaboration with Dr. Débora González and Dr. Alessio Faggioli, she is investigating the addition of ayahuasca to psychotherapy in patients with grief. Dóra is a psychedelic integration coach, and organizes several events in order to educate about the therapeutic role of psychedelics and their integration on Fuerteventura.

José Carlos Bouso

(Clinical psychologist, ICEERS, Spain)

José Carlos Bouso is a clinical psychologist and doctor in Pharmacology. He is the Scientific Director of ICEERS, where he coordinates studies on the potential benefits of psychoactive plants, mainly cannabis, ayahuasca and ibogaine.

Raúl del Pino

(Psychedelic specialist, writer and psychonaut, Spain)

Founder of Psiconautica.org in 1996, the first Spanish-language portal on drugs, he has focused on modified states of consciousness and transpersonal psychology. Author of the book MDMA, Sex and Tantra, Raúl combines scientific rigor with personal insights, exploring the relationship between psychoactives, sexuality and spiritual practices.

Lucas F. Borkel

(Neuropsychologist, Spain)

Lucas F. Borkel is the president of the Psychedelic Scientific Association (ACP). His background is in Philosophy and Neuropsychology. He combines teaching with research and scientific dissemination. His research focuses on the epistemology of psychedelic states and their risks, psychedelic phenomenology and consciousness studies.

Eduardo Hidalgo

(Psychologist, Spain)

Psychologist, master's degree in Drug Addiction, coordinator for ten years at Energy Control in Madrid. He is the author of several books, such as Sustainable Hedonism or Ketamine (Interzona Collection) and numerous articles in specialized magazines.

Rafael G. dos Santos

(Pharmacologist, Brazil)

He holds a Ph.D. in Pharmacology from the Universitat Autònoma de Barcelona and completed his post-doctoral studies at the Universidade de São Paulo. Currently, he is a Professor at the Faculty of Medicine of Ribeirão Preto - Universidade de São Paulo (USP), in the Department of Neurosciences and Behavioral Sciences. He has over 100 publications on hallucinogens, with more than 70 of these publications focusing on ayahuasca.

Antoniu Llort

(Anthropologist, Spain)

He holds a PhD and is a professor in Social and Cultural Anthropology, with a Master's degree in Medical Anthropology and Global Health from the Universitat Rovira i Virgili (URV) in Tarragona.

Marta Pérez Carmona

(Neuropsychologist, Spain)

Marta holds a degree in Psychology, a Master's in Neuropsychology, and a Master's in Psychoexpressive Therapy. She currently works as a co-director at Inawe and is a therapist in the first clinical trial with 5-MeO-DMT in Madrid. She is also a co-founder of the Psychedelic Society of Costa Rica and serves as a coordinator for the Psychedelic Society of Madrid. Her interest focuses on the resilient nature of the human being.

Carlos Alonso

(Engineer, INAWE, Spain)

Spanish engineer and entrepreneur, concerned about the current mental health crisis in the world, founded INAWE, a non-profit organization for the development of the psychedelic therapy ecosystem.

Juan París

(Psychiatrist, Spain)

A General and Child-Adolescent Psychiatrist of Venezuelan origin, he is a member of the psychedelic research team at Parc Sanitari Sant Joan de Déu in Barcelona. In this role, he serves as a researcher, guide, and therapist in psychedelic trials. Additionally, he is part of the board of directors of the Spanish Society of Psychedelic Medicine (SEMPsi). His primary clinical work is with the Migrant Assistance Service (SATMI).

Iker Puente

(Psychologist and Anthropologist, Spain)

Director of the Integrative Transpersonal Institute. He holds a PhD in Psychology from the Autonomous University of Barcelona and has degrees in Psychology and Social and Cultural Anthropology. He is trained in Transpersonal Psychotherapy and Holotropic Breathwork with Stanislav Grof, Gestalt Therapy, NLP, and Claudio Naranjo's SAT program, as well as in MDMA-assisted psychotherapy with the Multidisciplinary Association for Psychedelic Studies (MAPS).

Juan Carlos de la Cal

(Journalist, Spain)

A journalist with over 30 years of experience as a reporter in various national media outlets, specializing in social journalism. Now retired from the profession, he is a great connoisseur of the Amazon and Indigenous cultures, having produced numerous reports on issues affecting Amazonian culture and society. He is the vice president and co-founder of the Platform for the Defense of Ayahuasca (Plantaforma).

Celia Morgan

(Psychopharmacologist, United Kingdom)

Celia Morgan is Professor of Psychopharmacology at the University of Exeter. She earned her bachelor's and doctoral degrees at University College London (UCL) and completed a fellowship program at Yale University. She worked at the University of Melbourne and is an Honorary Reader at University College London. She is academic lead for both Exeter Translational Addiction Partnership (ETAP) and Ketamine for Reduction of Alcoholic Relapse (KARE).

Lorena Terene

(Researcher, Brazil)

Lorena Terene has a BSc in Biological Sciences and an MSc in Physiology and Pharmacology from the Universidade Federal de Minas Gerais. She has worked in basic research in neurobiology and has experience in behavioral neurobiology and molecular biology. A PhD student, she works with psychedelics and post-traumatic stress disorder.

Walter Ramiro López ASOMASHK Fuertedélica Psychedelic Conference Fuerteventura

Walter López

(Healer, Perú)

Walter Ramiro López López (Panshin Nima) is a Shipibo master (onanya) from the Ucayali region of Peru. Founder and president of the Association of Shipibo-Konibo Ancestral Doctors (ASOMASHK), an authority that represents more than 120 indigenous masters who heal with sacred plants.

Mateo Sánchez

(Researcher, Spain)

Mateo is a PhD candidate at the University of Amsterdam, where he has researched the political potentials of psychedelic substances. Theoretically, his work lies at the intersection of phenomenology, posthumanism, and Marxist analyses of political economy, among other areas.

J. Q. Arosa

(Science communicator, Fractalma, Spain)

Arosa has collaborated with the University Institute of Neuroscience (IUNE) and is currently studying Cognitive Science with a focus on Neuroscience, AI, and Physics. He is the founder and director of Fractalma, a non-profit project aimed at integrating neuroscience, psychology, and secular spirituality to publicly disseminate and translate scientific and technical knowledge into practical wisdom.

VENUE OF THE EVENT

Corralejo Auditorium

C/ Huriamen, 1 – Corralejo (Fuerteventura)
35660 Las Palmas de Gran Canaria

Information & Tickets

bUY TicketS!